Kimberly-Clark Shares Rise Following Better-Than-Expected Third Quarter Results
Kimberly-Clark (KMB) shares rose approximately 1.5% on Thursday after reporting third-quarter results that exceeded analyst expectations for earnings per share. While revenue saw a slight year-over-year decline of 0.4% to $4.13 billion, adjusted EPS of $1.70 beat the LSEG consensus estimate of $1.66. The performance highlights the company's defensive qualities during a period of volatility in tech-heavy indices like the Nasdaq. The company is also navigating its recent acquisition of Kenvue, which provides direct exposure to the consumer health sector through brands like Tylenol and Band-Aid. Management expects synergies from this merger to drive cost savings and sales growth by leveraging complementary geographic strengths and distribution networks. Despite some headwinds in legacy categories like skincare and oral care, leadership remains optimistic about business momentum.
Topics: acquisition defensive stocks earnings report EPS beat revenue
Part of the story Stellantis Shares Rise 14% Following Better-Than-Expected Q3 Results (4 articles)